← SynDRA
Lopac-S-153
SynDRA canonical compound SYN0851715 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ADCY1 |
|---|
| Mechanism of action | Adenylyl cyclase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Adenylyl cyclase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CBX1
- GLP1R
- GMNN
- KDM4A
- L3MBTL1
- RAPGEF4
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- NCGC00015912-01
- Lopac0_001192
- SQ-22536
- HMS3369D08
- Adenine, 9-(tetrahydro-2-furyl)-
- Adenine, 9-(tetrahydro-2-furanyl)-
- NCGC00261877-01
- NCGC00094445-02
- AKOS015998755
- s8283
- SR-01000075521-1
- 9-tetrahydrofuran-2-ylpurin-6-amine
- BDBM50009687
- BRD-A56987319-001-03-8
- T2172
- HMS3412B05
- orb1306224
- FT155955
- KBio2_005618
- NSC53339
- NCGC00015912-07
- M02495
- SQ 22,536
- SMR001230661
- 9-(Tetrahydrofuryl)-Adenine
- NCGC00015912-03
- MLS002667588
- NCGC00094445-04
- NCGC00094445-05
- HMS1792J03
- HSCI1_000170
- HMS2235P22
- NCGC00015912-05
- 9-(Tetrahydro-furan-2-yl)-9H-purin-6-ylamine
- BCBcMAP01_000102
- IDI1_002166
- NCGC00094445-01
- KBioGR_000482
- 9-(Tetrahydro-2-furyl)adenine
Look up Lopac-S-153 in the interactive SynDRA portal →